Intellectual Property In India: Novartis Sees Patent Protections To Be In Patients’ Best Interests (Part 3 of 3)

Novartis’ Gleevec patent battle in India has caught the attention of at least one U.S. lawmaker. Meanwhile, the outcome could impact Indian pharmas.